Tolterodine Tartrate
53 NDCs across 10 manufacturers|51 Generic,2 Brand
Tolterodine Tartrate is used to treat urinary bladder diseases and urinary incontinence, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Mar 25, 1998, and the first generic was approved Sep 25, 2012. FDA's Orange Book lists 28 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $71 million on Tolterodine Tartrate across 811,000 claims for 215,000 beneficiaries.
Tolterodine Tartrate is available as 53 NDCs from 10 manufacturers (51 generic, 2 brand), with NADAC prices from $0.20 to $13.23 per EA — the most expensive product costs about 65× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
53
51G / 2B
Manufacturers
10
competing in market
Price Spread
$0.20 – $13.23
per EA
7d Activity
avg -1.1% WoW · of 53 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Teva Pharmaceuticals USA Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Cholinergic Muscarinic Antagonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
10 manufacturers producing TOLTERODINE TARTRATE(2 pricing outliers)
Frequently Asked Questions
What is Tolterodine Tartrate used to treat?
Tolterodine Tartrate is used to treat urinary bladder diseases and urinary incontinence, per the National Library of Medicine's MED-RT classification.
When did Tolterodine Tartrate become available as a generic?
FDA approved the first generic Tolterodine Tartrate (ANDA) on Sep 25, 2012. The Orange Book currently lists 28 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Tolterodine Tartrate?
In 2024, Medicare Part D spent $71 million on Tolterodine Tartrate across 811,000 claims for 215,000 beneficiaries.
How many Tolterodine Tartrate products are on the market?
The Tolterodine Tartrate drug market contains 53 NDCs from 10 manufacturers — 51 generic and 2 brand products.
What is the price range for Tolterodine Tartrate?
NADAC reference prices for Tolterodine Tartrate range from $0.2037 to $13.2274 per EA — the most expensive product costs about 65× the cheapest.
Is generic Tolterodine Tartrate cheaper than brand?
The average generic NADAC for Tolterodine Tartrate is $0.2461 per EA, versus $13.2274 for brand-labeled products — brand versions average about 54× the generic price.
Which manufacturers make Tolterodine Tartrate?
10 manufacturers list Tolterodine Tartrate in NADAC. Ranked by number of NDCs, the largest are Teva Pharmaceuticals USA Inc. (9), Mylan Pharmaceuticals Inc. (8), Ajanta Pharma USA Inc. (6), ANI Pharmaceuticals, Inc. (6), Slate Run Pharmaceuticals LLC (6).
How has the price of Tolterodine Tartrate changed recently?
Over the past 7 days, 19 Tolterodine Tartrate NDCs rose and 16 fell, with a market-wide average change of -1.1%.